Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19)
Since late December 2019, an outbreak of 2019 novel coronavirus disease (COVID-19) in Wuhan, China has spread quickly nationwide. With the spread of COVID-19, the routine clinical diagnosis and treatment for lung cancer patients has been disturbed. Due to the systemic immunosuppressive of lung cance...
Main Authors: | Yan XU, Hongsheng LIU, Ke HU, Mengzhao WANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2020-03-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.02 |
Similar Items
-
Preliminary Recommendations for Lung Surgery during 2019 Novel Coronavirus Disease (COVID-19) Epidemic Period
by: Xin LI, et al.
Published: (2020-03-01) -
COVID-19 (Coronavirus Disease 2019): A New Coronavirus Disease
by: Sadeghi Dousari A, et al.
Published: (2020-08-01) -
Predicting the Epidemiological Outbreak of the Coronavirus Disease 2019 (COVID-19) in Saudi Arabia
by: Dabiah Alboaneen, et al.
Published: (2020-06-01) -
Novel Coronavirus Disease 2019 (COVID-19): An Emerging Infectious Disease in the 21st Century
by: Ahmad Tavakoli, et al.
Published: (2020-01-01) -
Clinical recommendations on lung cancer management during the COVID‐19 pandemic
by: Yan Xu, et al.
Published: (2020-07-01)